Erin Lavelle is a director of Neurogene Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
144
Neurogene Inc.
6 Feb 24
4
Neoleukin Therapeutics, Inc.
9 Jun 23
4
Eliem Therapeutics, Inc.
2 Nov 22
4
Neoleukin Therapeutics, Inc.
16 May 22
4
Eliem Therapeutics, Inc.
31 Jan 22
3
Eliem Therapeutics, Inc.
9 Aug 21
4
ALDER BIOPHARMACEUTICALS INC
24 Oct 19
4
ALDER BIOPHARMACEUTICALS INC
25 Apr 19
4
ALDER BIOPHARMACEUTICALS INC
8 Feb 19
3
ALDER BIOPHARMACEUTICALS INC
18 Apr 18
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 8 Jun 23 | NGNE Neurogene | Stock Option Common Stock | Grant | Acquire A | No | No | 0.79 | 25,000 | 19.75 k | 25,000 |